Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers

Clinical Cancer Research

Volumn 6, Issue 8, 2000, Pages 2999-3005

  Maxwell, G Larry ^a   Risinger, John I ^b   Hayes, Kate A ^b   Alvarez, Angeles A ^a   Dodge, Richard K ^a   Barrett, J Carl ^b   Berchuck, Andrew ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ADVANCED CANCER; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CHILD; ENDOMETRIUM CANCER; FEMALE; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN TISSUE; INFANT; MALE; MICROSATELLITE INSTABILITY; NEGRO; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; ENDOMETRIAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; NEOPLASM STAGING; PHOSPHORIC MONOESTER HYDROLASES; PROGNOSIS; PTEN PHOSPHOHYDROLASE; TUMOR SUPPRESSOR PROTEINS;

EID: 0033900089     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Ries, L. A. G., Kosary, C. L., Hankey, B. F., Miller, B. A., and Edwards, B. K. (eds.). SEER cancer statistics report, 1973-1975 report (monograph online). Bethesda, MD: National Cancer Institute, 1999.
2. Liu, J. R., Conaway, M., Soper, J. T., Clarke-Pearson, D. L., and Berchuck, A. Relationship between race and interval to treatment in endometrial cancer. Obstet. Gynecol., 86: 486-490, 1995.
3. Hill, H. A., Coates, R. J., Austin, H., Correa, P., Robboy, S. J., Chen, V., Click. L. A., Barrett, R. J., Boyce, J. G., and Kotz, H. L. Racial differences in tumor grade among women with endometrial cancer. Gynecol. Oncol., 56: 154-163, 1995.
4. Steinhorn, S. C., Myers, M. H., Hankey, B. F., and Pelham, V. F. Factors associated with survival differences between black women and white women with cancer of the uterine corpus. Am. J. Epidemiol., 124: 85-93, 1986.
5. Bain, R. P., Greenberg, R. S., and Chung, K. C. Racial differences in survival of women with endometrial cancer. Am. J. Obstet. Gynecol., 157: 914-923, 1987.
6. Ito, K., Watanabe, K., Nasim, S., Sasano, H., Sata, S., Yajima, A., Silverberg, S. G., and Garrett, C. T. Prognostic significance of p53 overexpression in endometrial cancer. Cancer Res., 54: 4667-4670, 1994.
7. Tahiro, H., Isacson, C., Levine, R., Kurman, R. J., Cho, K. R., and Hedrick, L. p53 gene mutations are common in uterine serous carcinoma and occur in their pathogenesis. Am. J. Pathol., 150: 177-185, 1997.
8. Kohler, M. F., Berchuck, A., Davidoff, A. M., Humphrey, P. A., Dodge, R. K., Iglehart, J. D., Soper, J. T., Clarke-Pearson, D. L., Bast, R. C., Jr., and Marks, J. R. Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res., 52: 1622-1627, 1992.
9. Lukes, A. S., Kohler, M. F., Pieper, C. F., Kerns, B. J., Bentley, R., Rodriguez, G. C., Soper, J. T., Clarke-Pearson, D. L., Bast, R. C., Jr., and Berchuck, A. Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer. Cancer (Phila.), 73: 2380-2385, 1994.
10. Clifford, S. L., Kaminetsky, C. P., Cirisano, F. D., Dodge, R., Soper, J. T., Clarke-Pearson, D. L., and Berchuck, A. Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer. Am. J. Obstet. Gynecol., 176: S229-S232, 1997.
11. Kohler, M. F., Carney, P., Dodge, R., Soper, J. T., Clarke-Pearson, D. L., Marks, J. R., and Berchuck, A. p53 overexpression in advanced-stage endometrial adenocarcinoma. Am. J. Obstet. Gynecol., 175: 1246-1252, 1996.
12. Tashiro, H., Blazes, M. S., Wu, R., Cho, K. R., Bose, S., Wang, S. I., Li, J., Parsons, R., and Hedrick Ellenson, L. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecologic malignancies. Cancer Res., 57: 3935-3940, 1997.
13. Risinger, J. I., Hayes, A. K., Berchuck, A., and Barrett, J. C. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res., 57: 4736-4738, 1997.
14. Kong, D., Suzuki, A., Zou, T. T., Sakurada, A., Kemp, L. W., Wakatsuki, S., Yokoyama, T., Yamakawa, H., Furukawa, T., Sato, M., Ohuchi, N., Sato. S., Yin, J., Wang, S., Abraham, J. M., Souza, R. F., Smolinski, K. N., Meltzer, S. J., and Horii, A. PTEN1 is frequently mutated in primary endometrial carcinomas. Nat. Genet.. 17: 143-144, 1997.
15. Risinger, J. I., Berchuck, A., Kohler, M. F., Watson, P., Lynch, H. T., and Boyd, J. Genetic instability of microsatellites in endometrial carcinoma. Cancer Res., 53: 5100-5103, 1993.
16. Simpkins, S. B., Bocker, T., Swisher, E. M., Mutch, D. G., Gersell, D. J., Kovatich, A. J., Palazzo, J. P., Fishel, R., and Goodfellow, P. J. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum. Mol. Genet., 8: 661-666, 1999.
17. Esteller, M., Levine, R., Baylin, S. B., Hedrick Ellenson, L., and Herman, J. G. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene, 17: 2413-2417, 1998.
18. Kobayashi, K., Matsushima, M., Koi, S., Saito, H., Sagae, S., Kudo, R., and Nakamura, Y. Mutational analysis of mismatch repair genes, hMLH1 and hMSH2. Jpn. J. Cancer Res., 87: 141-145, 1996.
19. Risinger, J. I., Hayes, K., Maxwell, G. L., Carney, M. E., Dodge, R. K., Barrett, J. C., and Berchuck, A. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics. Clin. Cancer Res., 4: 3005-3010, 1998.
20. Armitage, P. Statistical Methods in Medical Research. London: B lackwell Scientific Publications, 1971.
21. Hosmer, D. W., and Lemeshow, S. Applied Logistic Regression. New York, NY: John Wiley and Sons, 1989.
22. Cox, D. R. Regression models and life tables. J. R. Stat. Soc. B., 34: 187-202, 1972.
23. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
24. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
25. Hicks, M. L., Phillips, J. L., Parham, G., Andrews, N., Jones, W. B., Shingleton, H. M., and Menck, H. R. The National Cancer Database report on endometrial carcinoma in African-American women. Cancer (Phila.)., 83: 2629-2637, 1998.
26. Hussain, S. P., and Harris, C. C. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res., 58: 4023-4037, 1998.
27. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
28. Wang, X. W., and Harris, C. C. p53 tumor-suppressor gene: clues to molecular carcinogenesis. J. Cell. Physiol., 173: 247-255, 1997.
29. Scott, N., Sagar, P., Stewart, J., Blair, G. E., Dixon, M. F., and Quirke, P. p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br. J. Cancer, 63: 317-319, 1991.
30. Kohler, M. F., Marks, J. R., Wiseman, R. W., Jacobs, I. J., Davidoff, A. M., Clarke-Pearson. D. L., Soper, J. T., Bast, R. C., and Berchuck, A. Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J. Natl. Cancer Inst., 85: 1513-1519, 1993.
31. van der Kooy, K., Rookus, M. A., Peterse, H. L., and van Leeuwen, F. E. p53 protein overexpression in relation to risk factors for breast cancer. Am. J. Epidemiol., 144: 924-933, 1996.
32. Maehama, T., and Dixon, J. E. The tumor suppressor, PTEN/ MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem., 273: 13375-13378, 1998.
33. Tamura, M., Gu, J., Takino, T., and Yamada, K. M. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. Cancer Res., 59: 442-449, 1999.
34. Tamura, M., Gu, J., Danen, E. H., Takino, T., Miyamoto, S., and Yamada, K. M. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/ Akt cell survival pathway. J. Biol. Chem., 274: 20693-20703, 1999.
35. Guldberg, P., thor Strafen, P., Birck, A., Ahrenkiel, V., Kirkin, A. F., and Zeuthen, J. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res., 57: 3660-3663, 1997.
36. Cairns, P., Okami, S., Halachmi, N., Esteller, M., Herman, J. G., Jen, J., Isaacs, W. B., Bova, S., and Sidransky, D. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res., 57: 4997-5000, 1997.
37. Rasheed, B. K., Stenzel, T. T., McLendon, R. E., Parsons, R., Friedman, A. H., Friedman, H. S., Bigner, D. D., and Bigner, S. H. PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res., 57: 4187-4190, 1997.
38. Maxwell, G. L., Risinger, J. I., Gumbs, C., Shaw, H., Bentley, R. C., Barrett, J. C., Berchuck, A., and Futreal, P. A. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Cancer Res., 58: 2500-2503, 1998.
39. Sherman, M. E., and Kurman, R. J. Evolving concepts in endometrial carcinogenesis: importance of DNA repair and deregulated growth. Hum. Pathol., 29: 1035-1038, 1998.
40. Gurin, C. C., Federici, M. G., Kang, L., and Boyd, J. Causes and consequences of microsatellite instability in endometrial carcinoma. Cancer Res., 59: 462-466, 1999.
41. Duggan, B. D., Felix, J. C., Muderspach, L. I., Tourgeman, D., Zheng, J., and Shibata, D. Microsatellite instability in sporadic endometrial carcinoma. J. Natl. Cancer Inst., 86: 1216-1221, 1994.
42. Tibiletti, M. G., Furlan, D., Taborelli, M., Facco, C., Riva, C., Franchi, M., Cossu, A., Trubia, M., Taramelli, R., and Capella, C. Microsatellite instability in endometrial cancer: relation to histological subtypes. Gynecol. Oncol., 73: 247-252, 1999.
43. Sakamoto, T., Murase, T., Urushibata, H., Kato, K., Takada, H., Imamura, T., Mori, H., and Wake, N. Microsatellite instability and somatic mutations in endometrial carcinomas. Gynecol. Oncol., 71: 53-58, 1998.
44. Sirchia, S. M., Pariani, S., Rossella, F., Garagiola, I., De Andreis, C., Bulfamante, G., Zannoni, E., Radaelli, U., and Simoni, G. Cytogenetic abnormalities and microsatellite instability in endometrial adenocarcinoma. Cancer Genet. Cytogenet., 94: 113-119, 1997.